BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 13, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Juvista avotermin: Phase I data

In a U.S. Phase I trial in 50 patients, escalating doses of Juvista injected into the margins of a wound created by the surgical removal of a keloid from the earlobe at the time of wound closure and 24 hours later showed that the overall...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >